  See all
 | Articles: Demyelinating Disorders |
Cognitive dysfunction 24-31 years after isolated optic neuritis
Multiple Sclerosis, 06/25/08
Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings
Multiple Sclerosis, 06/25/08
Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada
Multiple Sclerosis, 06/25/08
 | | Sponsor |
Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study
Multiple Sclerosis, 06/25/08
Cost-Effectiveness Analyses of Natalizumab (Tysabri®) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK
PharmacoEconomics, 06/25/08
Factors associated with the risk of secondary progression in multiple sclerosis
Multiple Sclerosis, 06/25/08
Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland
Multiple Sclerosis, 06/25/08
Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence
Multiple Sclerosis, 06/25/08
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France
Multiple Sclerosis, 06/25/08
Improvement of hand dexterity following motor cortex rTMS in multiple sclerosis patients with cerebellar impairment
Multiple Sclerosis, 06/25/08
|
|
Receive daily email updates on Demyelinating Disorders
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
163 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
